HPV vaccine for women right after childbirth
Part of Infections, Women’s health & pregnancy clinical trials.
This study tests the 9-valent HPV vaccine in women who have recently given birth, within one week of delivery. The vaccine protects against several types of HPV that can cause cervical cancer and genital warts, and this research aims to see if it is safe and effective for postpartum women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Able to read and understand English
- No allergy to vaccine components
- No condition that weakens the immune system (like HIV or lupus)
- No history of taking immune-suppressing drugs in the past year
- No prior HPV vaccination
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well the Gardasil 9 HPV vaccine works in people assigned male at birth, including those with HIV and those taking hormone therapy. Results could help protect against HPV-related cancers.
This study looks at the safety and immune response of a 9-valent HPV vaccine. It is for women who have already received a full course of certain HPV vaccines and are now getting a different one to see if it boosts their immunity.
This trial tests whether getting the HPV vaccine after a LEEP (a procedure to remove abnormal cervical cells) can help prevent the abnormal cells from coming back. It's for women who have had high-grade cervical changes or very early cervical cancer.
This Phase 4 study tests whether a 9-type HPV vaccine (9vHPV) can reduce how infectious HPV is and lower the chance of HPV spreading in women who already have HPV16 and/or HPV18. It focuses on specific HPV-positive women recently diagnosed and compares what happens after vaccination.
This trial tests whether getting the HPV vaccine after treatment for vulvar high-grade lesions can help prevent the lesions from coming back. It is for women who have not been vaccinated before and are about to have treatment for this condition.
This study tests whether a single dose of the HPV vaccine is enough to protect against the viruses that cause several cancers. You will have the vaccine and some small tissue samples taken to see how your immune system responds.
Hear when a new Human Papilloma Virus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.